Abstract
Background & aim:
Low vision rehabilitation optimizes the use of residual vision after severe vision loss, but also teaches skills to improve visual functioning in daily life. These skills promote independence and active participation in society. This meta-analysis was designed to evaluate the efficacy of low vision rehabilitation in improving the quality of life (QoL) in visually impaired adults.
Methods:
We searched the Cochrane Library, PubMed, EMBASE, and Web of Science up to January 1, 2020. Randomized controlled trials (RCTs) that compared rehabilitation interventions with active or inactive controls were included. The standardized mean difference (SMD) with a 95% confidence interval (CI) was estimated to compare outcomes. Two reviewers extracted data and assessed trial quality independently. All statistical analyses were performed using the standard statistical procedures of RevMan 5.2.
Results:
A total of 52 RCTs with 6,239 participants were included in this meta-analysis. Compared to inactive comparators including waiting list or no care, low vision rehabilitation improved vision-related QoL, visual functioning (QoL: psychological aspect), and self-efficacy or self-esteem (QoL: psychological aspect), with pooled SMDs of −0.61 (95% CI −0.95 to −0.26; P = .0006), -1.14 (95% CI −1.69 to −0.59; P < .0001), and −0.84 (95% CI −1.47 to −0.22; P < .0001), respectively. Compared to active comparators, low vision rehabilitation improved vision-related QoL (SMD −0.26; 95% CI −0.46 to −0.06; P = .01) and activities of daily living (QoL: physical aspect) (SMD −0.39; 95% CI −0.67 to −0.12 P < .0001). However, no significant difference in health-related QoL and adaptation to vision loss (QoL: psychological aspect) was found between low vision rehabilitation and inactive comparators.
Conclusions:
This meta-analysis indicated that low vision rehabilitation interventions, particularly psychological therapies and methods of enhancing vision, may improve vision-related QoL and visual functioning in people with sight loss compared to usual care. Further studies should explore longer maintenance effects and the costs of several types of low vision rehabilitation. Studies characterizing the mechanisms of rehabilitation interventions in different settings, including low-income countries, are also required.
Keywords: efficacy, low vision rehabilitation, quality of life
1. Introduction
Approximately 216.6 million people have been estimated to have moderate to severe visual impairment (<6/18) and that 36 million people are blind.[1] Visual impairment is especially problematic in developing countries, where approximately 80% of all visually impaired persons live. Vision loss mainly affects older people; 82% of those who are blind and 65% of those with mild to severe vision loss are 50 years or older.[2] Vision loss is one of the leading causes of disability in older people.[3] Besides physical dysfunction, limitations in daily life activities, visual functioning, and anxiety, vision loss also leads to decreased life satisfaction and quality of life (QoL).[4–11]
Low vision rehabilitation for adults is a professional service that optimizes residual vision and also teaches visually impaired people skills to improve visual functioning in daily life. In addition, it helps patients to adapt to vision loss and improve psychosocial functioning. This may lead to greater independence and more active participation in society. Low vision rehabilitation should ultimately improve the QoL of visually impaired patients.
Several studies in the field of low vision rehabilitation have focused on objective tasks or specific measures of functional ability such as reading speed or other performance-based measures.[12] Although these measures are important to assess functioning, they do not capture all facets of the individual's experience.[13] Comprehensive patient-reported outcome measures such as health-related QoL and disease-specific QoL have been introduced because of the growing interest of governments and health insurance companies in these outcome measures as parameters for quality of care.[14–16] In the field of low vision, increasing attention has been focused on the theoretical constructs of vision-related QoL and visual functioning as important outcomes of rehabilitation. A comprehensive literature review by Binns and colleagues showed that the evidence supporting vision rehabilitation remains unclear with respect to health-related QoL or vision-related QoL.[17] However, the authors did not specifically assess methodological quality and included observational studies. Hence, this meta-analysis was designed to assess the effectiveness of low vision rehabilitation interventions on health-related QoL, vision-related QoL, and visual functioning and closely related patient-reported outcomes in visually impaired adults.
2. Methods
2.1. Criteria for considering studies
We included studies if they met the following criteria: a. Randomized controlled trials (RCTs) that compared one or more rehabilitation interventions with wait lists/no care or with usual care/other care; b. studies in which the effect of low vision rehabilitation was assessed among adults (≥18 years) of either gender with a vision impairment; and c. studies that measured health-related QoL and vision-related QoL as 2 primary outcomes or related patient-reported outcomes as secondary outcomes, such as physical and functional measures, psychological measures, and/or social measures, at any follow-up time after the intervention ended.
Studies were excluded if they met the following criteria: a. experimental trial on animals or a non-human study, non-RCTs, quasi-RCTs, or observational studies; b. study population included patients with other diseases that would affect outcomes; c. study reported in the form of an abstract, letter, editorial, expert opinion, review, or case report; or d. lack of sufficient data or failure to meet the inclusion criteria. We excluded studies focusing on the following interventions or devices: neuro-rehabilitation interventions, interventions to improve visual field loss after brain damage, medical interventions, and preferences regarding low vision aid designs.
The present study was approved by the Ethics Committee of Wangjing Hospital of Chinese Academy of Traditional Chinese Medicine.
2.2. Search strategy
We searched the Cochrane Library, PubMed, EMBASE, and Web of Science to January 1, 2020. Our strategy was based on combinations of keywords including “low vision,” “impaired vision,” “rehabilitation,” “intervention,” “quality of life,” and “visual function.” Two assessors independently screened the titles and abstracts of each study. When a relevant study was identified, its full text was obtained for further evaluation. The full text of related references was also obtained for review. References that met the inclusion criteria were also included in the meta-analysis.
2.3. Quality assessment and data extraction
Two reviewers assessed the quality of each RCT using the risk of bias assessment tool.[18] In addition, the risk of bias, for each individual study and across all studies, was evaluated and graphically displayed in figures generated by RevMan 5.2 software.[19]
Data for the comparative outcomes were extracted independently by 2 reviewers. Disagreements were resolved through discussion. The extracted data included first author, year of publication, sample size, intervention, participant age, follow-up time, and outcomes. These data were standardized and input into RevMan 5.2 software for analysis.[19]
2.4. Definition of intervention types
Considering the clinical diversity of low vision rehabilitation interventions, the studies were categorized into 4 groups of related intervention types (and by comparator):
Intervention type I: Psychological therapies and/or group programs;
Intervention type II: Methods of enhancing vision;
Intervention type III: Multidisciplinary rehabilitation programs;
Intervention type IV: Other programs.
Comparators were no care/waiting list as an inactive control group and usual care / other care as an active control group.
2.5. Statistical analysis
Data on study outcomes were combined and analyzed using the standard statistical procedures of RevMan 5.2.[19] Standardized mean difference (SMD) with a 95% confidence interval (CI) was estimated to compare the outcomes. The Ph value and I2 statistic (ranging from 0%–100%) derived the Chi-Squared-based Q test and were used to assess heterogeneity between studies.[20] A Ph value ≤.10 was deemed to represent significant heterogeneity;[21] in such cases, pooled estimates were calculated using a random-effects model (the DerSimonian and Laird method [22]). When heterogeneity was not observed (Ph >.10), a fixed-effects model (the Mantel–Haenszel method [23]) was used. Differences in outcome measures were considered significant if the 95% CI of the pooled SMD did not include 0.
Regarding the pooled SMD estimates of the improvement in vision-related QoL and visual functioning, we performed subgroup analysis by different intervention types. In addition, we checked for publication bias using Begg funnel plots.[24] If the shape of a funnel plot was not obviously asymmetrical, we concluded that there was no obvious publication bias.[25] All statistical analyses were performed using the standard statistical procedures of RevMan 5.2.[19]
The reporting in this study is consistent with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses[26] and Assessment of Multiple Systematic Reviews guidelines.[27]
3. Results
3.1. Characteristics of the included studies
The initial search generated 16,118 records. After removal of duplicates, 14,125 records remained, of which 13,904 were excluded after screening the title and abstracts. Following full-text review of the 221 studies chosen for further evaluation, 169 full texts were excluded, and 52 RCTs (N = 6239 participants) that met the inclusion criteria were included in the final analysis.[28–79] Of the 52 included studies, 26 studies were performed with intervention type I, 15 with intervention type II, 7 with intervention type III, and 4 studies with intervention type IV. In addition, 20 studies compared the intervention with inactive comparators, namely no care (6 studies) or wait list (14 studies), and 26 studies compared the intervention with active comparators including usual care (13 studies) or other care (13 studies). Most studies investigated the efficacy of low vision rehabilitation in older people with visual impairment (the mean age across 23 studies was >70 years, and the mean age of 13 studies was >80 years). Details of the search process and a summary of the studies are shown in the study flow diagram (Fig. 1). Other study characteristics are shown in Table 1.
Figure 1.

Flow diagram of literature search and selection of included studies for meta-analysis.
Table 1.
The characteristics of included studies for meta-analysis.
| Participants | Interventions | ||||||||
| Study/Year | Country | Total No. | Age (year) | Female | Treatment | Control | Intervention type | Follow-up time | Outcomes |
| Acton, JH, et al, 2016 | UK | 71 | 75.2 | 54% | 1 to 8 sessions/home visits from a visual rehabilitation officer | waiting list receiving no care | Type III | 6+4 mo | VR-QoL or difficulty in performing daily activities, consisting of mobility, visual motor skills, reading, visual information processing scales and an overall score, AEs |
| Bradley, P, et al, 2005 | UK | 12 | 76 | 50% | Group-based peer support and information provision, discussion groups, 6 leaflets with information were distributed in 6 weekly topic-specific sessions of 1.5 hours led by people experienced in living with AMD | waiting list, intervention delayed for 6 weeks | Type I | 6 wks | MacDQOL, selected QoL items, 12-item Well-being Questionnaire |
| Brody BL, et al, 1999 | USA | 92 | 79 ± 5.79 | 50% | self-management group focused on behavioural skills training for elderly adults with AMD who were legally blind in one or both eyes. 6 sessions of 2 hours in groups of 7–10 participants | Participants on the waiting list did not receive treatment | Type I | 6+4 wks | POMS, QWBS, AMD-SEQ, Health and impact Questionnaire |
| Brody BL, et al, 2002 | USA | 231 | 80.9 ± 6.1 | NR | Self-management group intervention in which 8–10 participants had six 2-h sessions led by an experienced professional in public health and behavioural medicine | a series of 12 h of audiotapes of health lectures on AMD and healthy ageing | Type I | 6+4.5 mo | POMS, NEI-VFQ mediators, AMD-SEQ, DSSI, LOT-R |
| Brody BL, et al, 2006 | USA | 32 | 81.5 ± 7.5 | NR | Self-management group intervention in which 8–10 participants had six 2-h sessions led by an experienced professional in public health and behavioural medicine | a series of 12 h of audiotapes of health lectures on AMD and healthy ageing | Type I | 6+4.5 mo | GDS-15: extent of depressive symptoms, NEI-VFQ, DSSI, LOT-R and AMD-SEQ |
| Brunnstrom G, et al, 2004 | Sweden | 46 | 76 (20–90) | NR | Improved lighting in the living room in addition to usual/basic lighting adjustments in other rooms | only usual, basic lighting adjustments in other rooms, no improved lighting in living room | Type II | 6 mo | PGWB = HR-QoL questionnaire, PGWB questionnaire, Factors on perceived QoL |
| Bryan JL, et al, 2015 | USA | 81 | 42 (20–74) | 69% | Expressive writing intervention, expressing emotions through written disclosure of a post-traumatic experience for 20 min on three separate d during a 1-wk period | neutral writing intervention, however, similar in dose and intensity | Type I | 3 and 6 wk, 1 wk, 6 wk | CES-D, PSS, NEI-VFQ, mental health subscale, Social support Physical symptoms, NEI-VFQ for VR-QoL |
| Burggraaff MC, et al, 2012 | Nether-lands | 122 | 77.4 | 58.2% | Usual instructions from supplier when CCTV was delivered combined with training sessions in the use of the device from a low vision therapist. | Received only usual instructions from the supplier who delivered the CCTV | Type II | 3+2 mo | Reading speed, LVQOL, AVL, CES-D, EQ-5D |
| Christy B, et al, 2010 | India | 436 | 43.7 (16–86) | 30% | Centre and/or community-based service delivery | Centre-based with non-interventional community visits | Type III | 9+4-5 mo | WHO-QoL for HR-QoL, daily activities |
| Coco-Martín MB, et al, 2013 | Spain | 41 | 76.1 ± 7.8 | 61% | Immediate intervention: low vision assessment, within 2 wks of enrolment | Participants on the waiting list did not receive treatment | Type I | 6+12 mo | Reading performance, QoL |
| Coco-Martín MB, et al, 2017 | Spain | 51 | 68.5 ± 13.8 | 61% | Reading rehabilitation program (RRP) | Participants on the waiting list did not receive treatment | Type I | 6 + 12 mo | The reading speed, reading duration, and font size. |
| Conrod BE, et al, 1998 | Canada | 49 | 70 | NR | Five weekly individual 1-hour training sessions in which participants, under supervision, followed a perceptual training protocol manual | Fully sighted persons, no training | Type I | 7–8 wks | Distance and near acuity, Frostig Figure Ground test, Coping, Activity level, Personal assessment of residual vision |
| Draper E, et al, 2016 | USA | 55 | 63-66 | 54% | Clinic-basedLVR: visit 1 to 5 in clinic | Home-based low vision rehabilitation: visit 1, 3, 5 in clinic; visit 2, 4 at home | Type III | 2–3 mo | VR-QoL: VFQ-48 |
| Dunbar HM, et al, 2013 | UK | 100 | 57 | 62% | Immediate intervention: low vision assessment, within 2 wks of enrolment | intervention, LV assessment, 3 months after enrolment, providing information,discussing aids and services and dispensing prescribed LV aids | Type II | 3 + 2.5 mo | Difference in mean change in Activity Inventory (visual ability) after 3 mo and after 6 mo |
| Eklund K, et al, 2008 | Sweden | 229 | 78 (66–91) | 74% | Health education programme ’Discovering new ways’, Two h a wk | Individual intervention programme, mainly consisted of 1-2 onehour sessions | Type I | 4 and 28, 6 mo | validated questionnaire, ADL staircase, SF-36: general HRQOL, Self-reported health problems |
| Gall C, et al, 2011 | Germany | 42 | 57.1 ± 13.6 | 31% | Centre and / or community-based service delivery | Fully sighted persons, no training | Type II | 2-mo | Visual field changes and vision-related quality of life |
| Girdler SJ, et al.2010 | Australia | 77 | 79.1 | 64.9% | usual care plus vision self-management, including self-efficacy and a group model based on service delivery theories and principles, 8-week (24 h) structured programme of welcome and warm-up exercises, learning sessions and homework assignments plus revisions | usual care, which was based on a one-to-one case management model. | Type I | 12 + 4 wks | Activity Card Sort (ACS), SF-36, GDS, GSES, AVLS, AMD-SEQ |
| Gleeson M, et al, 2015 | Australia | 120 | 75 ± 11 | 71% | Alexander Technique to improve balance + usual care by ’guide dogs’ and community services with 12 weekly sessions | Usual care by ’guide dogs’ and community services | Type IV | 12+9 mo | physical measures, falls, balance, mobility, GDS-5, PANAS, IVI, PVAS, KAP, Socialisation |
| Goldstein RB, et al, 2007 | USA | 154 | 77.5 (39–92) | 64.2% | educational video which addressed educational, emotional and motivational needs associated with LV | waiting list, received no care | Type I | 2 wks + 3 mo | Knowledge, Attitude, Behaviour, Willingness to use devices |
| Herrero AJ, et al, 2014 | Spain | 188 | 85.2 ± 6.682.7 ± 6.9 | 70.2% | in-home BA + LVR or ST + LVR. | waiting list control group | Type I | 4 mo | depressive disorder, activity inventory, NEI-VFQ, NEI-VFQ quality-of-life |
| Holloway E, et al, 2018 | USA | 18 | NR | NR | 6–8 weekly telephone sessions of PST-PC delivered by expertly trained practitioners | waiting list control group | Type II | 6–8 weekly | Depressive symptoms (PHQ-9), health-related quality of life (HRQoL; Assessment of QoL Instrument-7D), |
| Jackson ML, et al, 2017 | USA | 37 | 71 | 49% | Usual comprehensive vision rehabilitation with optical aids of preference, plus access to a desk model video magnifier | usual comprehensive vision rehabilitation with optical aids of preference | Type II | 1 mo | Reading speed in words per minute, IVI, DASS, AI-reading subscale |
| Kaltenegger K, et al, 2019 | Germany | 37 | 72 (67.5–79) | 57% | Reading training with sequentially presented text (RSVP) in addition to magnifying aids | placebo training in addition to magnifying aids | Type II | 12 wks | Reading speed, Fixation stability and preferred retinal locus, MADRS, DemTect, IVI |
| Kaluza G, et al, 1996 | Germany | 23 | 52 (20–68) | 78.2% | training to support peoples’ coping with the threats and demands of the disease and to enable them to self-regulate stress-induced elevated IOP levels | waiting list control group | Type I | 8 wks | Intraocular pressure (IOP), Psychological strain (KAB), Heart rate |
| Kamga H, et al, 2017 | Canada | 80 | 76 | 62% | cognitive behavioural therapy-based self-care tool intervention plus up to three coaching 10-minute phone calls by a trained former nurse | usual care: waiting list control group receiving the intervention after follow-up with one phone call | Type I | 8 wks | PHQ-9: depressive symptoms, GAD-7: generalised anxiety symptoms, Life Space assessment questionnaire, Self-efficacy scale |
| Leat SJ, et al, 2017 | Canada | 14 | 82 | 20% | eccentric viewing training within 1 week after randomisation 1.5-2 hrs and then home training with an observer giving feedback on accuracy | closed-circuit television delivered and set up within one week after randomisation at home | Type II | 6 wks | Reading accuracy and reading speed and performance, Reading behaviour inventory, VFQ-25: VR-QoL, GDS: depression |
| Luo RJ, et al, 2011 | China | 500 | NR | NR | provision of magnifying visual aids and training | waiting list control group | VRQL, the efficacy of rehabilitative treatments | ||
| McCabe P, et al, 2000 | USA | 97 | 76 (19–91) | 53.6% | Family rehabilitation intervention. The social work interview included an exploration of the meaning of vision loss for the family unit and the ways the family members worked together to adapt to the loss | individual rehabilitation intervention, which focused solely on the participant. Family members were excluded from all sessions | Type III | NR | Self-reported Functional Assessment Questionnaire (FAQ), Observer-rated FVPT |
| Mielke A, et al, 2013 | Germany | 20 | 79 (65–85) | 65% | provision of magnifying visual aids and training | waiting list, rehabilitation possible after 3 months | Type II | 3+2.5 mo | GDS, ADS-L, DemTecT, MMS, NEI-VFQ 25, IREST |
| Mozaffar Jalali MD, et al, 2014 | Iran | 60 | 20-40 | NR | group-based rational emotive behavioural therapy which is a comprehensive, active-directive psychotherapy focusing on resolving emotional and behavioural problems | no training | Type I | 1 mo | DASS, Jones irrational beliefs questionnaire, Eysenck's self-esteem inventory |
| Nollet CL, et al, 2016 | UK | 85 | 70 | 59% | trained therapists delivered a seven-step cognitive behavioural therapy to approach problems participants wanted to address. | no intervention other than a 6-wk low vision assessment | Type I | 6+4 mo | depressive symptoms, BDI-II, GDS-15, visual functioning, VR-QoL, reading ability |
| Pankow L, et al, 2004 | USA | 30 | 77.8 (65–90) | 56.7% | orientation & mobility training and/or blind rehabilitation teaching and/or LV evaluation | waiting list (education regarding ocular disease) | Type III | 4–6 wks, 3 to 3.5 mo | NAS2: Nottingham Adjustment Scale, FIMBA, performance with respect to living skills, orientation and mobility skills |
| Patodia Y, et al, 2017 | Canada | 16 | NR | NR | LV outpatient treatment including examination, prescription of low vision devices for 4-wk use to determine which would be most beneficial and single training session | LV examination, but no intervention | Type II | 4 wks | VA LV VFQ-48: VR-QoL, visual ability |
| Pearce E, et al.2011 | UK | 120 | 73.1 | 37.5% | A 1-hour appointment with a low vision support worker 2 weeks after the initial low vision assessment, reviewing handling of low vision devices, discussing daily issues at home, focusing on low vision devices | received a well-person check with a nurse, only measuring weight, height, vision and blood pressure | Type II | 1 and 3 mo, 2.5 mo | Assesses vision-related activities of daily living, social and recreational, low vision device handling |
| PinnigerR, et al, 2013 | Australia | 17 | 79.4 | 100% | Tango dance group programme; sessions of 1.5 hrs, twice a wk, during 4 wks | waiting list, only ’post test’ interview conducted | Type IV | 4 wks | NEI VFQ-25, SWL scale, GDS-short version, Rosenberg self-esteem scale |
| Rees G, et al, 2015 | Australia | 153 | 80 ± 8 | 60% | Group-based self-management programme focusing on coping with illness and disability. Weekly 3-h sessions for 8 wks offered by two LVR counsellors and guest speakers | usual care provided by a LVR service, initial assessment by multidisciplinary team, optometric assessment and prescription of optical aids, further training provided by the multidisciplinary team | Type I | 1 and 6 mo | Depressive, Anxiety and Stress Symptoms, IVI, GSES: self-efficacy, AVL: adaptation to Age-related Vision Loss, Impact of Vision Impairment, VR-QoL |
| Reeves BC, et al, 2004 | UK | 226 | 81 | 66.4% | CLVR provided by the hospital eye service and CLVR enhanced with home visits from a rehabilitation officer for the visually impaired | CLVR supplemented with home visits, from a community care worker, which did not include CELVR | Type III | 12 mo | VR-QoL core measure, SF-36, NAS, Measured task performance, LVA (Low Vision Aid) use |
| Rovner BW, et al, 2007 | USA | 206 | 81.2 | 69.9% | PST: teaching problem-solving skills, in addition to care-as-usual | usual care, provided by ophthalmologist or other health care providers | Type I | 2 and 6 mo | DSM-IV diagnosis of depression, HDRS, VA, Contrast sensitivity, NEI VFQ-17 |
| Rovner BW, et al, 2013 | USA | 241 | 82 | 63.5% | PST teaches problem-solving skills in a structured way to enable a participant to identify his problems, generate and select a solution | The ST therapists informed participants that its purpose was to explore the impact of vision loss on their lives | Type I | 3 and 6 mo | TVF, NEI VFQ 25 + supplement, AI, Physical health status, PHQ |
| Deemer AD, et al, 2017 | USA | 188 | 84 ± 7 | 70% | In home behavioural activation which focuses on targeting behaviours that might maintain/worsen depression + low vision rehabilitation | in-home supportive therapy controlling for the nonspecific effects of attention + low vision rehabilitation | Type I | 4+2 mo | PHQ-9, NEI-VFQ, AI: Activity Inventory, NEI-VFQ-25 plus |
| Rumrill PD. 1999 | USA | 48 | 43.6 (16–69) | 64.6% | 2 sessions and one follow along visit after 8 weeks, training by a rehabilitation professional | waiting list control | Type I | 16 wks | Accomodation self-efficacy, Accomodation activity, Americans with Disabilities Act knowledge |
| Scanlan JM, et al, 2004 | Canada | 64 | 81 | 64.1% | extended teaching programme in reading with microscopes, consisting of five onehour sessions at theLV clinic | traditional teaching session of 1-hour in reading with microscopes | Type II | 12+7 wks | NEI-VFQ, reading ability |
| Seiple W, et al, 2011 | USA | 36 | 79 / 78.5 | 50% | Visual awareness and eccentric viewing, Control of reading eye movements, Reading practice with sequential presentation of lexical information | delayed treatment for 18 weeks | Type II | 18 wks | Reading performance, VR-QoL, HR-QoL, depressive symptoms, adaptation to vision loss |
| Smith HJ, et al, 2005 | UK | 243 | 81 | 64.6% | Custom treatment: incorporating bilateral prisms to match participants’ preferred power and base direction; Standard treatment: incorporating standard bilateral prisms | placebo, consisting of spectacles matched in weight and thickness to prism spectacles but without the prism | Type II | 3 mo | logMAR VA, Reading speed performance, NEI-VFQ-25, activities of daily living performance, helpfulness and use of test spectacles |
| Stelmack JA, et al, 2008 | USA | 126 | 78.9 | 98% | 5 weekly sessions (approximately 2 hours per session) at the LV clinic to learn strategies for more effective use of remaining vision and use of LV devices | Treatment was delayed for 4 mo | Type III | 4+2 mo | change in visual reading ability, mobility, visual information processing, visual motor skills and overall visual ability |
| Stelmack JA, et al, 2017 | USA | 323 | 80 ± 10.5 | 97% | LV devices with a rehabilitation therapist providing instruction and homework on the use of low vision devices, eccentric viewing, and environmental modification | Receiving LV devices with no therapy | Type II | 4 mo, 3 to 3.5 mo | Reading, visual information, visual motor, and mobility, reading speed, critical print size, and reading acuity |
| Stroupe KT, et al, 2018 | USA | 323 | 80 ± 10.5 | 2.8% | Low-vision devices with therapy | LV devices without therapy | Type IV | 4 mo | changes in functional visual ability, costs |
| Sun W, et al, 2012 | China | 100 | 62 (25–75) | NR | Psychological therapy, however, specific content unclear + physical therapy by an ophthalmologist | physical therapy, however, specific content unclear | Type I | 6 mo | SDS, SAS, SCL-90 |
| Taylor JJ, et al, 2017 | UK | 100 | 71 | 62% | Portable electronic device on top of nonelectronic optical devices | Nonelectronic optical devices | Type II | 2 and 4 mo | Reading measurements, instrumental activities of daily living, NV-VFQ-15, EQ-5D, VR-QoL |
| Tey CS, et al, 2019 | Singa-pore | 165 | 60.2 ± 11.3 | 36.2% | LV self-management programme on top of usual care in which participants picked a goal they wished to achieve, focus on learning process of new techniques to enhance activities of daily living, providing information | Standard ophthalmologic care and low vision aid training and referral to occupational or mobility training at the participant's request | Type I | 2 wks and 6 mo | IVI-28: VR-QoL, DASS, GSES, EQ-5D and SF-12: HR-QoL |
| Van der Aa HPA, et al, 2017 | Nether-Lands, Belgium | 265 | 74 | 70% | Stepped-care (+ usual care) by supervised occupational therapists, social workers, and psychologists from low vision rehabilitation organisations | Usual care by rehabilitation centre or any other healthcare service | Type I | at least 12 mo | Cumulative incidence of depression and anxiety disorder after 24 mo measured with the MINI diagnostic interview |
| Waterman H, et al, 2016 | UK | 49 | 81 (65–96) | 65% | Home safety programme by occupational therapist visiting twice and making safety modifications plus one phone call | Usual care from NHS three social visits, two telephone calls by trained lay visitors/volunteers | Type IV | 3 and 6 mo | Falls and injurious falls, Physical activity, SF-12: QoL, visual disability, VR-QoL, AFRIS |
AEs = adverse events, AMD = age-related macular degeneration, AFRIS = Attitudes to Falls-Related Interventions Scale, AMD-SEQ = age-related macular degeneration-self efficacy questionnaire, AI = activity inventory, BA = behavior activation, BDI-II = Beck Depression Inventory – II, CCTV = closed-circuit television, CES-D = center for epidemiologic studies-depression scale, DSSI = Duke Social Support Index, FVPT = functional visual performance test, HR-QoL = Heath-related quality of life, IVI = impact of visual impairment profile, Intervention type I = psychological therapies and/or group programmes, Intervention type II = methods of enhancing vision, Intervention type III = multidisciplinary rehabilitation programmes, Intervention type IV = other programmes, LVR = low vision rehabilitation, LV = low vision, LVQOL = low vision quality of life questionnaire, LOT-R = Life Orientation Test-Revised, LVR = low vision rehabilitation, MINI = mini-international neuropsychiatric interview, MacDQOL = macular degeneration quality of life questionnaire, MADRS = Montgomery–Åsberg Depression Rating Scale, NHS = National Health Service, NEI-VFQ = National Eye Institute visual functioning questionnaire, POMS = profile of mood states, PST = problem solving treatment, PHQ-9 = patient health questionnaire-9-item version PGWB = Psychological and General Well-Being scale, QoL = quality of life, QWBS = Quality of Well-Being Scale, SDS = Self-rating Depression Scale, SAS = Self-rating Anxiety Scale, SCL-90 = Symptom Checklist 90-items, TVF = targeted vision function, VR-QoL = vision-related quality of life, VRQL = vision-related quality of life.
3.2. Quality assessment
Risk-of-bias graphs were generated to assess the quality of studies. Data on the risk of bias for each RCT and across RCTs are presented as percentages (see Figure 1 and 2, Supplemental Digital Content which illustrate the Risk of bias as percentages and summary of each included study). The risk-of-bias graphs indicated generally good methodological quality. Most studies had adequate (low risk) random sequence generation, as random number tables, computer random number generators, or other low-tech methods were used to randomize participants. Risks due to blinding issues were unclear in previous studies because, in the field of low vision, most trials used a pragmatic approach in which masking of participants and personnel were not possible. The risk of attrition bias in most studies was considered low because follow-up rates and compliance were similar in the groups, and analyses were often based on the intention-to-treat principle with limited attrition. For 10 studies, attrition bias was unclear, and another 10 studies seemed to have a high risk. The unclear risk of bias was observed mainly in performance and reporting bias.
3.3. Effects of low vision rehabilitation on vision-related QoL
Thirteen studies including 922 participants compared low vision rehabilitation with wait list or no care addressing vision-related QoL. As shown in Figure 2, compared to wait list or no care, low vision rehabilitation improved vision related QoL, with pooled SMDs of −0.61 (95% CI −0.95 to −0.26; P = .0006). As significant heterogeneity was observed (I2 = 82%), pooled analysis was conducted using the random-effect model. We further conducted subgroup analysis according to different intervention types. Subgroup analysis revealed significant difference between low vision rehabilitation and wait list or no care with regard to vision-related QoL, with pooled SMDs of −0.28 (95% CI −0.47 to −0.08) for intervention type I, but no significant different for intervention type II and III, with pooled SMD of −0.19 (95% CI −0.54 to 0.15) and −1.04 (95% CI −2.24 to 0.17) respectively (Table 2).
Figure 2.

Forest plot of comparison between low vision rehabilitation and waiting list or no care with regard to vision-related QoL.
Table 2.
The efficacy of low vision rehabilitation with regard to vision-related QoL for patients with impaired vision.
| Pooled results | ||||||
| Subgroups | No. of studies | No. of patients | SMD | 95% CI | P value | Analytical effect model |
| Compared with waiting list or no care | ||||||
| Intervention type I | 4 | 433 | -0.28 | −0.47, −0.08 | .005 | Fixed-effect model |
| Intervention type II | 5 | 180 | −0.82 | −1.67, 0.03 | .06 | Random-effect model |
| Intervention type III | 4 | 309 | −0.77 | −1.62, 0.08 | .07 | Random-effect model |
| Compared with active comparator | ||||||
| Intervention type I | 7 | 1245 | −0.11 | −0.24, 0.01 | Random-effect model | |
| Intervention type II | 8 | 660 | −0.24 | −0.40, −0.08 | Random-effect model | |
| Intervention type III | 3 | 464 | 0.01 | −0.18, 0.20 | Random-effect model | |
| Intervention type IV | 2 | 163 | −0.21 | −0.53, 0.10 | Random-effect model | |
SMD = standardized mean difference, CI = confidence intervals.
Eighteen studies including 2342 participants compared the effects of low vision rehabilitation with active comparators on vision-related QoL. As shown in Figure 3, compared to active comparators, low vision rehabilitation was more successful in improving vision-related QoL, with a pooled SMD of −0.15 (95% CI −0.25 to −0.04; P = .007). As significant heterogeneity was observed (I2 = 35%), pooled analysis was conducted using the random-effect model. We further conducted subgroup analysis according to different intervention types. Significant results were observed for intervention type II, with pooled SMDs of −0.24 (95% CI −0.40 to −0.08). However, we observed no significant difference between active comparators and low vision rehabilitation using intervention types I (SMD −0.11; 95% CI −0.24 to 0.01), III (SMD 0.01; 95% CI −0.18 to 0.20), and IV (SMD −0.21; 95% CI −0.53 to 0.10) (Table 2).
Figure 3.

Forest plot of comparison between low vision rehabilitation and active comparator with regard to vision-related QoL.
3.4. Effects of low vision rehabilitation on visual functioning
Nine studies including 693 participants compared low vision rehabilitation with wait list or no care in terms of their effects on visual functioning. As shown in Figure 4, compared to wait list or no care, low vision rehabilitation was more successful in improving visual functioning, with a pooled SMD of −0.86 (95% CI −1.40 to −0.33; P = .002). As significant heterogeneity was observed (I2 = 90%), the pooled analysis was conducted using the random-effect model. We further conducted subgroup analysis according to different intervention types. Subgroup analysis revealed differences between low vision rehabilitation and wait list or no care for their effects on visual functioning; pooled SMDs were −1.23 (95% CI −2.18 to −0.28) for intervention type I and −0.86 (95% CI −1.50 to −0.23) for intervention type II. However, no significant difference was found for intervention type III, with a pooled SMD of −0.16 (95% CI −0.44 to 0.13) (Table 3).
Figure 4.

Forest plot of comparison between low vision rehabilitation and waiting list or no care with regard to visual functioning.
Table 3.
The efficacy of low vision rehabilitation with regard to visual functioning for patients with impaired vision.
| Pooled results | |||||
| Subgroups | No. of studies | No. of patients | SMD | 95% CI | Analytical effect model |
| Compared with waiting list or no care | |||||
| Intervention type I∗ | 5 | 456 | −1.23 | −2.18, −0.28 | Random-effect model |
| Intervention type II∗ | 2 | 44 | −0.86 | −1.50, −0.23 | Random-effect model |
| Intervention type III | 2 | 193 | −0.16 | −0.44, 0.13 | Random-effect model |
| Compared with active comparator | |||||
| Intervention type I∗ | 9 | 1334 | −0.14 | −0.25, −0.04 | Fixed-effect model |
| Intervention type II | 3 | 162 | −0.22 | −0.59, 0.15 | Fixed-effect model |
| Intervention type IV | 1 | 120 | 0.03 | −0.33, 0.39 | – |
SMD = standardized mean difference, CI = confidence intervals.
Twelve studies including 1453 participants compared low vision rehabilitation with active comparators in terms of changes in visual functioning. As shown in Figure 5, compared to active comparators, low vision rehabilitation more successfully improved visual functioning, with pooled SMDs of −0.13 (95% CI −0.23 to −0.03; P = .01). As no significant heterogeneity was observed (I2 = 0%), the pooled analysis was conducted using the fixed-effect model. Our subgroup analysis showed significant improvement of visual functioning with low vision rehabilitation using intervention type I, with a pooled SMD of −0.14 (95% CI −0.25 to −0.04). However, no significant difference in the improvement in visual functioning was found between active comparators and low vision rehabilitation using intervention types II (SMD −0.22; 95% CI −0.59 to 0.15) and IV (SMD 0.03; 95% CI −0.33 to 0.39) (Table 3).
Figure 5.

Forest plot of comparison between low vision rehabilitation and active comparator with regard to visual functioning.
3.5. Effects of low vision rehabilitation on health-related QoL
Compared to wait list or no care, low vision rehabilitation did not result in greater improvement in health-related QoL, with a pooled SMD of 0.02 (95% CI −0.23 to 0.28). No significant result was found based on subgroup analyses (intervention type I: SMD 0.26; 95% CI −0.28 to 0.80; intervention type II: SMD −0.08; 95% CI −0.37 to 0.21). Compared to active comparators, low vision rehabilitation showed no greater improvement in health-related QoL (SMD −0.08; 95% CI −0.18 to 0.03), nor was there greater improvement for any of the subgroups (intervention type I: SMD −0.09; 95% CI −0.39 to 0.20; type II: SMD −0.09; 95% CI −0.28 to 0.09; type III: SMD −0.10; 95% CI −0.31 to 0.12; intervention type IV: SMD -0.05; 95% CI −0.70 to 0.60) (Table 4).
Table 4.
The efficacy of low vision rehabilitation with regard to health-related QoL for patients with impaired vision.
| Pooled results | |||||
| Subgroups | No. of studies | No. of patients | SMD | 95% CI | Analytical effect model |
| Compared with waiting list or no care | 3 | 237 | 0.02 | −0.23, 0.28 | Fixed-effect model |
| Intervention type I | 1 | 54 | 0.26 | −0.28, 0.80 | – |
| Intervention type III | 2 | 183 | −0.08 | −0.37, 0.21 | Fixed-effect model |
| Compared with active comparator | 9 | 1461 | −0.08 | −0.18, 0.03 | Fixed-effect model |
| Intervention type I | 4 | 600 | −0.09 | −0.39, 0.20 | Fixed-effect model |
| Intervention type II | 2 | 443 | −0.09 | −0.28, 0.09 | Fixed-effect model |
| Intervention type III | 2 | 375 | −0.10 | −0.31, 0.12 | Fixed-effect model |
| Intervention type IV | 1 | 43 | −0.05 | −0.70, 0.60 | Fixed-effect model |
SMD = standardized mean difference, CI = confidence intervals.
3.6. Effects of low vision rehabilitation on other aspects of QoL
In addition, Compared to wait list or no care, no significant difference was observed in activities of daily living and adaptation to vision loss, with pooled SMDs of −0.04 (95% CI −0.33 to 0.26) and −0.11 (95% CI −0.51 to 0.29), respectively. However, we found significant improvement in self-efficacy or self-esteem with low vision rehabilitation (SMD −0.84; 95% CI −1.47 to −0.22). Compared to active comparators, no significant difference between low-vision rehabilitation and active comparators was found for activities of daily living (SMD −0.15; 95% CI −0.37 to 0.07). However, significant improvement in activities of daily living was found with intervention type I (SMD −0.39; 95% CI −0.67 to −0.12). In addition, no significant difference was observed between low vision rehabilitation and active comparators in self-efficacy or self-esteem (for all subgroups) or adaptation to vision loss (for all subgroups) (Table 5).
Table 5.
The efficacy of low vision rehabilitation with regard to other QoL for patients with impaired vision.
| Pooled results | |||||
| Subgroups | No. of studies | No. of patients | SMD | 95% CI | Analytical effect model |
| Compared with waiting list or no care | |||||
| Activities of daily living | 2 | 181 | −0.04 | −0.33, 0.26 | Fixed-effect model |
| Self-efficacy or self-esteem∗ | 5 | 550 | −0.84 | −1.47, −0.22 | Random-effect model |
| Adaptation to vision loss | 2 | 97 | −0.11 | −0.51, 0.29 | Fixed-effect model |
| Compared with active comparator | |||||
| Activities of daily living | 3 | 328 | −0.15 | −0.37, 0.07 | Fixed-effect model |
| Intervention type I∗ | 2 | 208 | −0.39 | −0.67, −0.12 | Fixed-effect model |
| Intervention type IV | 1 | 120 | 0.11 | −0.25, 0.47 | – |
| Self-efficacy or self-esteem | 5 | 560 | −0.10 | −0.27, 0.06 | Fixed-effect model |
| Intervention type I | 4 | 427 | −0.06 | −0.26, 0.15 | Fixed-effect model |
| Intervention type III | 1 | 133 | −0.22 | −0.56, 0.12 | – |
| Adaptation to vision loss | 6 | 993 | −0.08 | −0.20, 0.05 | Fixed-effect model |
| Intervention type I | 3 | 495 | −0.11 | −0.28, 0.07 | Fixed-effect model |
| Intervention type II | 1 | 122 | −0.30 | −0.65, 0.06 | – |
| Intervention type III | 2 | 376 | −0.02 | −0.24, 0.19 | Fixed-effect model |
SMD = standardized mean difference, CI = confidence intervals.
3.7. Publication bias
Begg funnel plots were generated to assess publication bias in the included studies. As shown in Figure 6, no obvious asymmetry was present, indicating a lack of publication bias.
Figure 6.

Begg funnel plot for detecting publication bias (vision-related QoL, health-related QoL, and visual functioning).
4. Discussion and conclusion
Low vision rehabilitation for adults is a professional service to optimize residual vision and also teaches visually impaired people to improve (visual) functioning in daily life. Other goals may be to help patients adapt to vision loss or improve psychosocial functioning. This may lead to greater independence and more active participation in society. Low vision rehabilitation should ultimately improve the QoL of visually impaired patients.
Low vision rehabilitation is not available everywhere, and when available, it is organized differently in nearly every country. Some countries may have multidisciplinary in- or outpatient centers, where occupational therapists, optometrists, low vision specialists, clinical physicists, psychologists, social workers, mobility and orientation trainers, and computer trainers work together.[1] Other countries have a single-service system, where, for example, the prescription of optical aids is completed by 1 organization, and social work is provided by another. In addition, in some countries, outpatient services are linked to ophthalmology departments, for example, in academic hospitals, whereas in others, this is not the case.[5] Individual or group sessions with social workers or psychologists seem to be increasingly common, as are home environment assessments and training sessions for the use of optical or other aids (e.g., canes) and low vision software.[16] Training in leisure time or vocational activities is also an important aspect of rehabilitation. Depending on agreements between organizations or policies in different countries, low vision rehabilitation services may be provided by commercial, non-profit, or charity organizations.[68]
In this review, we adopted a broad perspective to map and summarize evidence from RCTs in which several types of rehabilitation interventions were evaluated with the goal of improving QoL in adults with low vision. We adopted both health-related QoL and vision-related QoL as primary outcomes because general and disease-specific measures are used across medical specialties so that policy makers can make informed decisions about resources. The interpretation of our results is complicated by the fact that low vision rehabilitation is not a standard process, as interventions are highly tailored and can vary in different settings, where a mixture of different optometric or therapeutic components are used. For this reason, we grouped the study interventions into 4 broad categories. Unlike several other Cochrane Reviews, which present results by comparison, in the main text, we have presented effects on an outcome basis, which allows us to explore the consistency of the effects of several types of low vision rehabilitation interventions on each QoL, vision-related QoL, or related outcome.[11,15] Heterogeneity was mainly found in the analysis of vision-related QoL and depression. We performed subgroup analyses and also found significant heterogeneity except the analysis of other QoL. For analysis with significant heterogeneity, we used random-effect models to analyze the results to eliminate the influence of heterogeneity. Considering small number of studies in each subgroup, we did not perform sensitivity analysis. The obvious heterogeneity may mainly cause by the multiple interventions the studies used, though we summarized these interventions and classified different types.
Our results indicated that some low vision rehabilitation interventions, particularly psychological therapies and methods of enhancing vision, may improve vision-related QoL and visual functioning in people with sight loss better than usual care. Although various rehabilitation interventions were used across studies, our comparison of low vision rehabilitation and active or inactive comparators was consistent. For vision-related QoL and visual functioning, comparisons of low vision rehabilitation with both active and inactive comparators showed significantly greater improvement. In addition, the effect size for comparisons with inactive comparators was larger than that for active comparators (SMD of −0.46 for inactive comparators and −0.15 for active comparators for vision-related QoL; SMD = −0.86 for inactive comparators and −0.13 for active comparators for visual functioning). This consistency may support the potential benefits of active rehabilitation interventions for low vision.
A limitation of our results is that participants in the included studies were mainly individuals with age-related macular degeneration living in high-income countries. Further studies are required in middle- and low-income countries if low vision services are available. Other “forgotten” subgroups, which should be separately addressed, are young and working age adults. Only 1 (unfortunately rather low quality) RCT was found that addressed work-related issues when living with vision loss. As the prevalence of visual impairment in working age adults and children is low, we encourage collaboration with other (inter-) national research groups in organizing adequately powered trials providing more and stronger evidence on the effectiveness of rehabilitation programs. Apart from QoL in younger adults, these outcomes should focus on return to work. Other subgroups should receive more attention regarding the implementation of effective interventions, for example, people with multiple disabilities, such as intellectual disabilities or concurrent hearing disabilities. Another potential limitation of our methodology is the use of the SMD, which is the most common pooling method for instruments that use different scales. Finally, in clinical practice, training in the use of modern devices such as user-friendly computer software, tablets, and smartphones specifically for visually impaired individuals are increasingly offered. These interventions may increase participation, but further studies are required to evaluate their effectiveness and cost-effectiveness. Finally, the diversity of visual acuity and visual field in the visual impaired patients may affect the quality of life, which was failed to evaluate in this analysis and may lead to any risk of bias in the results. Thus, future propensity score matched studies should be conducted to avoid these multiple risk factors.
The present meta-analysis indicated that some low vision rehabilitation interventions, particularly psychological therapies and methods of enhancing vision, may improve vision-related QoL and visual functioning in people with sight loss compared to usual care. Further studies should explore the longer maintenance effects and costs of several types of low vision rehabilitation. Studies on the mechanisms of rehabilitation interventions in different settings, including low-income countries, are also required.
Author contributions
Conceptualization: Jianhua Liu, Weidong Zhang, Jiangzhou Guo.
Data curation: Jianhua Liu, Weidong Zhang, Jiangzhou Guo.
Formal analysis: Jianhua Liu, Weidong Zhang.
Methodology: Jige Dong, Yaping Chen.
Software: Jianhua Liu, Yaping Chen, Jiangzhou Guo.
Validation: Jige Dong, Shuai Tong.
Writing – original draft: Jianhua Liu, Jige Dong, Yaping Chen, Shuai Tong.
Writing – review & editing: Shuai Tong, Jiangzhou Guo.
Supplementary Material
Supplementary Material
Footnotes
Abbreviations: CI = confidence interval, QoL = quality of life, RCTs = randomized controlled trials, SMD = standardized mean difference.
How to cite this article: Liu J, Dong J, Chen Y, Zhang W, Tong S, Guo J. Low vision rehabilitation in improving the quality of life for patients with impaired vision: a systematic review and meta-analysis of 52 randomized clinical trials. Medicine. 2021;100:19(e25736).
The authors have no funding and conflicts of interests to disclose.
All data generated or analyzed during this study are included in this published article [and its supplementary information files].
Supplemental digital content is available for this article.
References
- [1].Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e888–97. [DOI] [PubMed] [Google Scholar]
- [2].Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614–8. [DOI] [PubMed] [Google Scholar]
- [3].Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001;108:1893–900. [DOI] [PubMed] [Google Scholar]
- [4].Bookwala J, Lawson B. Poor vision, functioning, and depressive symptoms: a test of the activity restriction model. Gerontologist 2011;51:798–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Hayman KJ, Kerse NM, LaGrow SJ, et al. Depression in older people: visual impairment and subjective ratings of health. Optom Vis Sci 2007;84:1024–30. [DOI] [PubMed] [Google Scholar]
- [6].Kempen GIJM, Ballemans J, Ranchor AV, et al. The impact of low vision on activities of daily living, symptoms of visual functioning, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Quality Life Res 2012;21:1405–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Van der Aa HPA, Krijnen-de Bruin E, Van Rens GHMB, et al. Watchful waiting for subthreshold visual functioning and anxiety in visually impaired older adults. Quality Life Res 2015;24:2885–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Stelmack JA, Tang XC, Wei Y, et al. The effectiveness of low-vision rehabilitation in 2 cohorts derived from the Veterans Affairs low-vision intervention trial. Arch Ophthalmol 2012;130:1162–8. [DOI] [PubMed] [Google Scholar]
- [9].Van Nispen RMA, De Boer MR, Hoeijmakers JGJ, et al. Co-morbidity and visual acuity are risk factors for health related quality of life decline: five months followup EQ-5D data of visually impaired older patients. Health Quality Life Outcomes 2009;7:18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Bruijning JE, Van Rens GHMB, Knol DL, et al. Psychometric analyses to improve the dutch ICF activity inventory. Optom Vis Sci 2013;90:806–19. [DOI] [PubMed] [Google Scholar]
- [11].Massof RW, Deremeik JT, Park WL, et al. Self-reported importance and difficulty of driving in a low-vision clinic population. Ophthalmic Epidemiol 2007;48:4955–62. [DOI] [PubMed] [Google Scholar]
- [12].Virgili G, Acosta R, Bentley SA, et al. Reading aids for adults with low vision. Cochrane Database Syst Rev 2018;4:CD003303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Scott IU, Smiddy WE, SchiDman J, et al. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 1999;128:54–62. [DOI] [PubMed] [Google Scholar]
- [14].Amtmann D, Cook KF, Johnson KL, et al. The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research. Arch Phys Med Rehabil 2011;92: Suppl 10: S12–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Massof RW, Deremeik JT, Park WL, et al. Visual function assessment questionnaires. Surv Ophthalmol 2001;45:531–48. [DOI] [PubMed] [Google Scholar]
- [16].Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vis Sci 2001;78:335–42. [DOI] [PubMed] [Google Scholar]
- [17].Binns AM, Bunce C, Dickinson C, et al. How dective is low vision service provision? A systematic review. Surv Ophthalmol 2012;57:34–65. [DOI] [PubMed] [Google Scholar]
- [18].Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011;Available from www.cochrane-handbook.org. [Google Scholar]
- [19].Review Manager (RevMan) [Computer Program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration 2012. [Google Scholar]
- [20].Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820–6. [DOI] [PubMed] [Google Scholar]
- [21].University of York Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York: CRD, University of York; 2009. [Google Scholar]
- [22].DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials 2015;45(Pt A):139–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–48. [PubMed] [Google Scholar]
- [24].Lin L. Graphical augmentations to sample-size-based funnel plot in meta-analysis. Res Synth Methods 2019;10:376–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Marston Sedgwick P. How to read a funnel plot in a meta-analysis. BMJ 2015;351:h4718. [DOI] [PubMed] [Google Scholar]
- [26].Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Acton JH, Molik B, Court H, et al. EDect of a home visit-based low vision rehabilitation intervention on visual function outcomes: an exploratory randomized controlled trial. Investig Ophthalmol Vis Sci 2016;57:6662–7. [DOI] [PubMed] [Google Scholar]
- [29].Bradley P, Mitchell J, Bradley C. Peer support for people newly diagnosed with macular degeneration: a pilot study. Int Congrs Ser 2005;1282:211–5. [Google Scholar]
- [30].Brody BL, Roch-Levecq AC, Gamst AC, et al. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol 2002;120:1477–83. [DOI] [PubMed] [Google Scholar]
- [31].Brody BL, Roch-Levecq AC, Kaplan RM, et al. Age-related macular degeneration: self-management and reduction of depressive symptoms in a randomized, controlled study. J Am Geriatr Soc 2006;54:1557–62. [DOI] [PubMed] [Google Scholar]
- [32].Brody BL, Williams RA, Thomas RG, et al. Age-related macular degeneration: a randomized clinical trial of a self-management intervention. Ann Behav Med 1999;21:322–9. [DOI] [PubMed] [Google Scholar]
- [33].Brunnstrom G, Sorensen S, Alsterstad K, et al. Quality of light and quality of life - the eDect of lighting adaptation among people with low vision. Ophthalmic Physiol Opt 2004;24:274–80. [DOI] [PubMed] [Google Scholar]
- [34].Bryan JL, Lu Q. Vision for improvement: expressive writing as an intervention for people with Stargardt's disease, a rare eye disease. J Health Psychol 2016;21:709–19. [DOI] [PubMed] [Google Scholar]
- [35].BurggraaD MC, Nispen RM, Knol DL, et al. Randomized controlled trial on the eDects of CCTV training on quality of life, visual functioning, and adaptation to vision loss. Investig Ophthalmol Vis Sci 2012;53:3645–52. [DOI] [PubMed] [Google Scholar]
- [36].BurggraaD MC, Van Nispen RMA, Hoeben FP, et al. Randomized controlled trial on the eDects of training in the use of closed-circuit television on reading performance. Investig Ophthalmol Vis Sci 2012;53:2142–50. [DOI] [PubMed] [Google Scholar]
- [37].Christy B, KeeDe JE, Nirmalan PK, et al. A randomized controlled trial assessing the eDectiveness of strategies delivering low vision rehabilitation: design and baseline characteristics of study participants. Ophthalmic Epidemiol 2010;17:203–10. [DOI] [PubMed] [Google Scholar]
- [38].Conrod BE, Overbury O. The eDectiveness of perceptual training and psychosocial counseling in adjustment to the loss of vision. J Vis Impair Blind 1998;92:464–82. [Google Scholar]
- [39].Deemer AD, Massof RW, Rovner BW, et al. Functional outcomes of the low vision visual functioning prevention trial in age-related macular degeneration. Investig Ophthalmol Vis Sci 2017;58:1514–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [40].Draper E, Feng R, Appel SD, et al. Low vision rehabilitation for adult African Americans in two settings. Optom Vis Sci 2016;93:673–82. [DOI] [PubMed] [Google Scholar]
- [41].Dunbar HM, Crossland MD, Bunce C, et al. The eDect of low vision rehabiltation in diabetic eye disease: a randomised controlled trial protocol. Ophthalmic Physiolog Opt 2012;32:282–93. [DOI] [PubMed] [Google Scholar]
- [42].Eklund K, Sjostrand J, Dahlin-Ivano DS. A randomized controlled trial of a health-promotion programme and its eDect on ADL dependence and self-reported health problems for the elderly visually impaired. Scand J Occup Ther 2008;15:68–74. [DOI] [PubMed] [Google Scholar]
- [43].Girdler SJ, Boldy DP, Dhaliwal SS, et al. Vision self-management for older adults: a randomised controlled trial. Br J Ophthalmol 2010;94:223–8. [DOI] [PubMed] [Google Scholar]
- [44].Gleeson M, Sherrington C, Lo S, et al. Can the Alexander Technique improve balance and mobility in older adults with visual impairments? A randomized controlled trial. Clin Rehabil 2015;29:244–60. [DOI] [PubMed] [Google Scholar]
- [45].Goldstein RB, Dugan E, Trachtenberg F, et al. The impact of a video intervention on the use of low vision assistive devices. Optom Vis Sci 2007;84:208–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [46].Jackson ML, Schoessow KA, Selinova A, et al. Adding access to a video magnifier to standard vision rehabilitation: initial results on reading performance and well-being from a prospective, randomized study. Digit J Ophthalmol 2017;23:1–0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [47].Kaltenegger K, Stephan Kuester S, Altpeter-Ott E, et al. EDects of home reading training on reading and quality of life in AMD—a randomized and controlled study. Graefes Arch Clin Exp Ophthalmol 2019;257:1499–512. [DOI] [PubMed] [Google Scholar]
- [48].Kaluza G, Strempel I, Maurer H. Stress reactivity of intraocular pressure aHer relaxation training in open-angle glaucoma patients. J Behav Med 1996;19:587–98. [DOI] [PubMed] [Google Scholar]
- [49].Kamga H, McCusker J, YaDe M, et al. Self-care tools to treat depressive symptoms in patients with age-related eye disease: a randomized controlled clinical trial. Clin Exp Ophthalmol 2017;45:371–8. [DOI] [PubMed] [Google Scholar]
- [50].Leat SJ, Si FF, Gold D, et al. The experience of a randomized clinical trial of closed-circuit television versus eccentric viewing training for people with agerelated macular degeneration. J Vis Impair Blind 2017;111:354–68. [Google Scholar]
- [51].McCabe P, Nason F, Demers TP, et al. Evaluating the defectiveness of a vision rehabilitation intervention using an objective and subjective measure of functional performance. Ophthalmic Epidemiol 2000;7:259–70. [DOI] [PubMed] [Google Scholar]
- [52].Mielke A, Wirkus K, Niebler R, et al. The influence of visual rehabilitation on secondary depressive disorders due to age-related macular degeneration. A randomized controlled pilot study. Ophthalmologe 2013;110:433–40. [DOI] [PubMed] [Google Scholar]
- [53].MozaDar Jalali MD, Moussavi MS, Amin Yazdi SA. Defectiveness of rational emotive behavior therapy on psychological well-being of people with late blindness. J Ration Emot Cogn Behav Ther 2014;32:23–47. [Google Scholar]
- [54].Nollet CL, Bray N, Bunce C, et al. Visual functioning in visual impairment trial (DEPVIT): a randomized clinical trial of visual functioning treatments in people with low vision. Investigative Ophthalmology & Visual Science 016;57:4247-54. [DOI] [PubMed] [Google Scholar]
- [55].Pankow L, Luchins D, Studebaker J, et al. Evaluation of a vision rehabilitation program for older adults with visual impairment. Top Geriatr Rehabil 2004;20:223–32. [Google Scholar]
- [56].Patodia Y, Golesic E, Mao A, et al. Clinical defectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss. Clin Ophthalmol 2017;11:683–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [57].Pearce E, Crossland MD, Rubin GS. The delicacy of low vision device training in a hospital-based low vision clinic. Br J Ophthalmol 2011;95:105–8. [DOI] [PubMed] [Google Scholar]
- [58].Pinniger R, Brown RF, Thorsteinsson EB, et al. Tango programme for individuals with age-related macular degeneration. Br J Vis Impair 2013;31:47–59. [Google Scholar]
- [59].Rees G, Xie J, Chiang PP, et al. A randomised controlled trial of a self-management programme for low vision implemented in low vision rehabilitation services. Patient Educ Couns 2015;98:174–81. [DOI] [PubMed] [Google Scholar]
- [60].Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial. Br J Ophthalmol 2004;88:1443–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [61].Reeves BC, Harper RA, Russell WB. Preventing visual functioning in age-related macular degeneration. Arch Gen Psychiatry 2007;64:886–92. [DOI] [PubMed] [Google Scholar]
- [62].Rovner BW, Casten RJ, Hegel MT, et al. Improving function in age-related macular degeneration - a randomized controlled trial. Ophthalmology 2013;120:1649–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [63].Scanlan JM, Cuddeford JE. Low vision rehabilitation: a comparison of traditional and extended teaching programs. J Vis Impair Blind 2004;98:601–11. [Google Scholar]
- [64].Seiple W, Grant P, Szlyk JP. Reading rehabilitation of individuals with AMD: relative defectiveness of training approaches. Investig Ophthalmol Vis Sci 2011;52:2938–44. [DOI] [PubMed] [Google Scholar]
- [65].Smith HJ, Dickinson CM, Cacho I, et al. A randomized controlled trial to determine the defectiveness of prism spectacles for patients with age-related macular degeneration. Arch Ophthalmol 2005;123:1042–50. [DOI] [PubMed] [Google Scholar]
- [66].Stelmack JA, Tang C, Reda DJ, et al. Outcomes of the veterans a dairs low vision intervention trial (LOVIT). Arch Ophthalmol 2008;126:608–17. [DOI] [PubMed] [Google Scholar]
- [67].Stelmack JA, Tang XC, Wei Y, et al. Outcomes of the veterans a dairs low vision intervention trial II (LOVIT II): a randomized clinical trial. JAMA Ophthalmol 2017;135:96–104. [DOI] [PubMed] [Google Scholar]
- [68].Stroupe KT, Stelmack JA, Tang XC, et al. Economic evaluation of low-vision rehabilitation for veterans with macular diseases in the US department of veterans a dairs. JAMA Ophthalmol 2018;136:524–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [69].Sun W, Wu F, Kong J, et al. Analysis on the psychological factors of glaucoma and the influence of the psychological therapy aHer the education on the Glaucoma Club. Int Eye Sci 2012;12:1619–22. [Google Scholar]
- [70].Taylor JJ, Bambrick R, Brand A, et al. Defectiveness of portable electronic and optical magnifiers for near vision activities in low vision: a randomised crossover trial. Ophthalmic Physiolog Opt 2017;37:370–84. [DOI] [PubMed] [Google Scholar]
- [71].Tey CS, Man REK, Fenwick EK, et al. Defectiveness of the “living successfully with low vision” selfmanagement program: results from a randomized controlled trial in Singaporeans with low vision. Patient Educ Coun 2019;102:1150–6. [DOI] [PubMed] [Google Scholar]
- [72].Van der Aa HPA, Van Rens GHMB, Bosmans JE, et al. Economic evaluation of stepped-care versus usual care for visual functioning and anxiety in older adults with vision impairment: randomized controlled trial. BMC Psychiatry 2017;17: Article number: 280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [73].Waterman H, Ballinger C, Brundle C, et al. A feasibility study to prevent falls in older people who are sight impaired: the VIP2UK randomised controlled trial. Trials 2016;17:464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [74].Coco-Martín MB, Cuadrado-Asensio R, López-Miguel A, et al. Design and evaluation of a customized reading rehabilitation program for patients with age-related macular degeneration. Ophthalmology 2013;120:151–9. [DOI] [PubMed] [Google Scholar]
- [75].Coco-Martín MB, López-Miguel A. Reading performance improvements in patients with central vision loss without age-related macular degeneration after undergoing personalized rehabilitation training. Curr Eye Res 2017;42:1260–8. [DOI] [PubMed] [Google Scholar]
- [76].Gall C, Sgorzaly S, Schmidt S, et al. Noninvasive transorbital alternating current stimulation improves subjective visual functioning and vision-related quality of life in optic neuropathy. Brain Stimul 2011;4:175–88. [DOI] [PubMed] [Google Scholar]
- [77].Herrero AJ, Pastor JC, Maldonado MJ, et al. Low vision visual functioning prevention trial in age-related macular degeneration: a randomized clinical trial. Curr Eye Res 2014;121:2204–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [78].Holloway E, Sturrock B, Lamoureux E, et al. Delivering problem-solving treatment in low-vision rehabilitation: a pilot feasibility study. Rehabil Psychol 2018;63:349–56. [DOI] [PubMed] [Google Scholar]
- [79].Luo RJ, Liu SR, Tian Z, et al. Rehabilitation of vision disorder and improved quality of life in patients with primary open angle glaucoma. Chin Med J (Engl) 2011;124:2687–91. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
